Key points are not available for this paper at this time.
Messenger RNA (mRNA) technology has emerged as a transformative force in the field of vaccine development and therapeutic applications, revolutionizing the landscape of modern medicine. This cutting-edge technology enables the rapid and flexible design of vaccines and therapeutics, unleashing a new era of personalized and targeted treatments. During the COVID-19 pandemic, mRNA vaccines demonstrated their immense potential by facilitating the swift development and deployment of highly effective vaccines against SARS-CoV-2, contributing significantly to the global response against the virus. Beyond infectious diseases, mRNA technology has opened new frontiers in cancer immunotherapy, offering personalized and therapeutic cancer vaccines that stimulate robust immune responses against tumors. Furthermore, mRNA technology is being explored for the treatment of genetic disorders, autoimmune diseases, and allergies, demonstrating its versatility and broad therapeutic potential. The rapid scalability and production of mRNA vaccines and therapeutics also present opportunities to address global health inequities by ensuring wider accessibility and distribution, particularly in low- and middle-income countries. Ongoing research efforts aim to further stabilize mRNA formulations, enhance delivery systems, and expand the range of target diseases, including neurological disorders and zoonotic infections. As innovation and collaboration continue to drive advancements in mRNA technology, its impact on global health and personalized medicine is poised to expand, promising more effective, targeted, and personalized medical solutions. Ultimately, mRNA technology represents a groundbreaking advancement in biomedical science, with the potential to transform healthcare delivery and improve outcomes across diverse medical fields
Vidhyalakshmi et al. (Thu,) studied this question.